The University of Texas Health Science Center at San Antonio Clinical Trials
Sponsors / The University of Texas Health Science Center at San Antonio
According to ClinicalTrials.gov, The University of Texas Health Science Center at San Antonio has served as lead sponsor on 199 registered trials. Across the portfolio, 28 are in recruitment, 4 are active non-recruiting, and 136 have reached completion. 16 trials have been terminated or withdrawn. The most common reasons cited for termination include funding constraints, slow or insufficient recruitment. Across the portfolio, planned enrollment totals 14,177 participants. Data on this page mirrors the ClinicalTrials.gov registry as of the most recent refresh.
199
Total Trials
28
Recruiting
4
Other Active
136
Completed
16
Terminated / Withdrawn
14,177
Total Enrollment
Termination reasons: Funding38% · Other38% · Recruitment13% · PI/or_Site13%
Recent Terminations
- Gingival Recession"The study team experienced an increased number of complications than expected"
- Posttraumatic Stress Disorder"Nonrandomized, open-label study terminated at the end of the program's funding cycle."
- Urinary Bladder Neoplasms"PI left the institution"
- Opioid Abuse, Unspecified"PI leaving institution"
- Bladder Cancer"Poor accrual of subjects and lack of funding"
- Insulin Sensitivity"Study drug expired"
- New Onset Atrial Fibrillation"Investigator left institution"
- Muscle Invasive Bladder Cancer"Study ended due to lack of eligible subjects and funding not renewing"
- Depression
- NCT01808833 Stopped Nov 2013Cancer
Active Trials (4 total)
- NCT06580509
- NCT06811324
- PTSD NANCT07351305
- Acute Kidney Injury PHASE2/PHASE3NCT06531642
- NCT06648642
- NCT03894917
- NCT07154693
- PTSD NANCT07176273
- NCT06628505
- Aging NANCT07168525
- NCT05094115
- NCT06173804
- NCT06507709
- NCT07053969
- NCT07054008
- Breast Cancer Metastatic PHASE1NCT07137871
- Hypoglycemia EARLY_PHASE1NCT00992901
- Post-bariatric Surgery EARLY_PHASE1NCT01803451
- Colon Cancer EARLY_PHASE1NCT02891538
- NCT05889741